What is Immuno-oncology Assay Market Scope?
Immuno-oncology refers to the use of the body's natural defenses to treat cancer and works by stimulating the immune system instead of fighting the tumors, avoiding disturbance in the functionality of healthy cells. The immuno-oncology assay is a type of immunoassay primarily used for cancer diagnosis. Further, ongoing clinical trials for the development of innovative products for cancer treatment is driving the immuno-oncology assay market.
The market study is being classified by Type (Consumables and Software), by Application (Research & Development and Clinical Diagnostics) and major geographies with country level break-up.
The Global Immuno-oncology Assay Market is fragmented with numerous market players. The key players in the market are focused on launching new products in the market, which is also expected to be another factor to drive market growth. Further, increasing incidence rate of cancer with various research and development activities, owing to benefits related to cancer treatment is propelling the market growth Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Immuno-oncology Assay market throughout the predicted period.
Thermo Fischer Scientific (United States), Roche Diagnostics (Switzerland), Agilent Technologies (United States), Illumina (United States), NanoString Technologies, Inc. (United States), Sartorius Group (Germany), Foundation Medicine, Inc. (United States), HTG Molecular Diagnostics, Inc. (United States), Qiagen (Germany), Merck & Co.(United States), PerkinElmer, Inc (United States), Nexelis (United States) and NeoGenomics Laboratories, Inc. (United States) are some of the key players profiled in the study.
AdvanceMarketAnalytics has segmented the market of Global Immuno-oncology Assay market by Type, Application and Region.
On the basis of geography, the market of Immuno-oncology Assay has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
In 2018, Roche collaborated with SQZ Biotech to develop antigen-presenting cells-based immune-oncology treatments.
In Mar 2020, Nexelis is pleased to announce the signing of a definitive agreement, subject to conditions precedent, to acquire ImmunXperts., and In Mar 2019, NeoGenomics, Inc. announced the availability of the Ventana PD-L1 (SP142) Assay for tumor tissue from patients with the triple-negative subtype of breast cancer.
Influencing Market Trend
- Introduction of Multiplex Assays
- Increasing Incidence of Cancer and Increasing Adoption of Targeted Therapy
- Growing Cases of Melanoma
- Rise in Adoption of Personalized Medicines
- Rising Focus on Biomarker Development
- Increasing Demand for Better Healthcare Services in Developing Economies
- Unfavorable Regulatory and Reimbursement Scenario
- High Cost of Immunotherapy Treatment
- High Attrition Rate in the Product Development Cycle
- High Amount of Capital Investments and Low Benefit-Cost Ratio
Key Target AudienceImmuno-oncology Assay Manufacturers, Pharmaceutical Companies, Marketing and Consulting Firms, Industry Associations, Downstream Vendors, Potential Investors and Distributors/Traders/Suppliers
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.